NASS 2019 Annual Meeting

Abstract Presentations: Cervical Spine Surgery I (Room Room W470b)

Moderator: Samuel C. Overley, MD

 

10. Cervical decompression surgery improves dynamic balance in cervical spondylotic myelopathy patients
Ram Haddas, PhD, MSc, MEng1; Rajesh G. Arakal, MD2; Theodore A. Belanger, MD3; Akwasi Boah, MD4
1Texas Back Institute, Plano, TX, US; 2Plano, TX, US; 3Texas Back Institute, Rockwall, TX, US; 4Texas Back Institute - Denton, Denton, TX, US
<

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

11. Predicting disability and pain outcomes one year after elective surgery for degenerative cervical diseases: analysis from quality outcomes database
Inamullah Khan, MD1; Clinton J. Devin, MD1; Hui Nian, PhD2; Frank E. Harrell Jr., PhD1; Jacquelyn S. Pennings, PhD1; Mohamad Bydon, MD3; Ahilan Sivaganesan, MD1; Kristin R. Archer, PhD, DPT1
1Vanderbilt University Medical Center, Nashville, TN, US; 2Nashville, TN, US; 3Mayo Clinic, Rochester, MN, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

12. Angiotensin-II type-1 receptor blockade decreased T2 signal intensity in spinal cord compression in symptomatic cervical spondylotic myelopathy
Alexander Perdomo-Pantoja, MD1; Alejandro Chara, BS2; Joshua Casaos, BS2; Samuel Kalb, MD; Corinna Zygourakis, MD3; Zach Pennington, BS2; Ethan Cottrill, MS2; Amir Manbachi, PhD4; Timothy F. Witham, MD, FACS1; Nicholas Theodore, MD2
1Johns Hopkins University School of Medicine, Baltimore, MD, US; 2Baltimore, MD, US; 3Stanford Department of Neurosurgery, Stanford, CA, US; 4Johns Hopkins University Department of Biomedical Engineering, Baltimore, MD, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

13. Minimally invasive posterior cervical foraminotomy as an alternative to anterior cervical discectomy and fusion for unilateral cervical radiculopathy
Nikhil K. Sahai, MD, MPH1; Stuart Changoor, MD2; Conor J. Dunn, MD3; Kimona Issa, MD4; Michael J. Faloon, MD5; Kumar G. Sinha, MD5; Ki Soo Hwang, MD5; Arash Emami, MD5
1St. Joseph's Regional Medical Center/Seton Hall University, Paterson, NJ, US; 2St. Joseph's University Medical Center, Paterson, NJ, US; 3St. Joseph's Regional Medical Center, Paterson, NJ, US; 4East Orange, NJ, US; 5University Spine Center, Wayne, NJ, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion

 

14. Day surgery anterior cervical discectomy and fusion at one, two and three levels is safe and effective in a public health system; experience from 273 patients at a single Canadian institution
Jamie R. Wilson, MbChB, FRCS1; Hetshree Joshi2; Jessica P. Bauer1; Fan Jiang, MD1; Eric M. Massicotte, MD, MBA, MSc2
1Toronto Western Hospital, Toronto, ON, Canada; 2University of Toronto, Toronto, ON, Canada

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

15. Surgical treatment of lower cervical fracture dislocation with spinal cord injuries using the anterior approach: a ten year case review with minimum five year follow-up
Biao Wang, MD1; Ding-Jun Hao, MD2
1Honghui Hospital, Xi'an, Shaanxi, China; 2Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

16. Discrepancies in the surgical management of central cord syndrome: assessment of nonoperative, surgical, and crossover to surgery patients
Peter G. Passias, MD1; Cole Bortz, BA2; Katherine E. Pierce, BS2; Haddy Alas, BS3; Avery Brown, BS3; Nicholas Shepard, MD3; Muhammad B. Janjua, MD4; Paul Park, MD5; Dimitrios C. Nikas, MD6; John A. Buza III, MD, MS3; Aaron Hockley, MD, FRCSC7; Anthony K. Frempong-Boadu, MD8; Dennis Vasquez-Montes, MS, BA3; Bassel G. Diebo, MD9; Michael C. Gerling, MD10
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2New York, NY, US; 3Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 4Dallas, TX, US; 5University Of Michigan Department of Neurosurgery, Ann Arbor, MI, US; 6University of Illinois at Chicago, Chicago, IL, US; 7University of Alberta, Edmonton, AB, Canada; 8NYU Medical Center Department of Neurosurgery, New York, NY, US; 9Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 10NYU Langone, Brooklyn, Brooklyn, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

17. The impact of preoperative cannabis on outcomes following cervical spinal fusion: a propensity score-matched analysis
Neil V. Shah, MD, MS1; Cameron R. Moattari, BS2; Joshua D. Lavian, BA1; Marine Coste, BA3; David Kim, BS1; Sirish Khanal, BS1; Joseph Scollan, BS4; George A. Beyer, MS1; Patrick J. Morrissey, BA1; Nathan S. Kim, BA2; Peter G. Passias, MD5; Renaud Lafage, MSc6; Han Jo Kim, MD6; Carl B. Paulino, MD1; Frank J. Schwab, MD6; Virginie Lafage, PhD6; Bassel G. Diebo, MD7
1SUNY Downstate Medical Center, Brooklyn, NY, US; 2Brooklyn, NY, US; 3SUNY Downstate Medical Center, New York, NY, US; 4SUNY Downstate, Brooklyn, NY, US; 5NY Spine Institute, NYU Langone Health, New York, NY, US; 6Hospital for Special Surgery, New York, NY, US; 7Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

18. Safety and efficacy of tranexamic acid use in posterior cervical decompression and fusion surgery
Joseph P. Gjolaj, MD1; Roberto J. Perez Roman, MD2; Karthik Madhavan, MD2; Julian Lugo-Pico, MD3
1University of Miami & Jackson Memorial Hospital Department of Orthopaedic Surgery, Miami, FL, US; 2Miami, FL, US; 3Jackson Memorial Hospital, Miami, FL, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion